GO2 Foundation for Lung Cancer

Founded by patients and survivors, GO2 Foundation for Lung Cancer transforms survivorship as the world's leading organization dedicated to saving, extending, and improving the lives of those vulnerable, at risk, and diagnosed with lung cancer. We work to change the reality of living with lung cancer by ending stigma, increasing public and private research funding, and ensuring access to care.

Latest from GO2 Foundation for Lung Cancer

GO2 Foundation Seeks to Better Understand Needs of People with Small Cell Lung Cancer

May 11, 2021

Article

Innovative effort aims to improve outcomes for historically underserved lung cancer patient community.

Offering Hope in the Lung Cancer Community

April 24, 2021

Article

In partnership with CURE®, Bonnie J. Addario and the GO2 Foundation for Lung Cancer will release “The Living Room: A Lung Cancer Community of Courage,” a collection of stories from patients, caregivers and survivors taking a personal approach to cancer care.

Task Force Recommends Lowering Age for Lung Cancer Screening, Including Individuals with Shorter Smoking History

March 10, 2021

Article

The US Preventive Services Task Force now recommends lowering the age and smoking history requirements for people to receive annual lung cancer screening.

GO2 Foundation Leads Study to Improve Participation of Black Communities in Lung Cancer Clinical Trials

March 09, 2021

Article

The GO2 Foundation for Lung Cancer (GO2 Foundation) announced its leadership in the launch of an important multi-institutional study to determine how to improve the participation of Black communities in lung cancer clinical trials.

New Study Seeks Origins of Young Lung Cancer

February 23, 2021

Article

Addario Lung Cancer Medical Institute and GO2 Foundation for Lung Cancer to learn about environmental, lifestyle, and demographic risks of developing lung cancer under the age of 40.

Real-World Patients May Have More Side Effects to Immunotherapy for Lung Cancer Compared With Clinical Trial Data

January 20, 2021

Article

Findings from a study focused on patient-reported experiences, found that aching joints, aching muscles and fatigue were more common than initially found in clinical trials.